Company · CIK 0001629137 · SIC 2834 — Pharmaceutical Preparations
Global Blood Therapeutics, Inc. · GBT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2017 JForm 5 → | Feb 14, 2018, 9:59 pm EST | Charles J HomcyDirector | 225,687 | — | — | 79,229 | — | plan? |
| Apr 6, 2017 SForm 4 → | Apr 10, 5:30 pm EDT | Robert I Tepper10% Owner | 31,225 | $33.23 | $1,037,576 | 229,773 | −12.0% | plan? |
| Apr 6, 2017 JForm 4 → | Apr 6, 4:00 pm EDT | Third Rock Ventures II, L.P. +510% Owner | 2,000,000 | — | — | 4,475,191 | — | plan? |
| Mar 2, 2017 SForm 4 → | Mar 6, 7:49 pm EST | Charles J HomcyDirector | — | — | — | 0 | — | plan? |
| Mar 2, 2017 SForm 4 → | Mar 6, 7:47 pm EST | Third Rock Ventures II, L.P. +810% Owner | 2,045,294 | $25.54 | $52,245,476 | 146,208 | −93.3% | plan? |
| Dec 16, 2016 SForm 4 → | Dec 20, 5:46 pm EST | Kevin P Starr10% Owner | 108,955 | $16.00 | $1,743,345 | 82,544 | −56.9% | plan? |
| Dec 14, 2016 JForm 4 → | Dec 16, 4:06 pm EST | Third Rock Ventures II, L.P. +510% Owner | 2,000,000 | — | — | 7,475,191 | — | plan? |
| Nov 14, 2016 GJForm 5/A → | Feb 14, 2018, 9:57 pm EST | Charles J HomcyDirector | 60,086 | — | — | 15,043 | — | plan? |
| Nov 14, 2016 SForm 4 → | Nov 16, 4:12 pm EST | Third Rock Ventures II, L.P. +810% Owner | 2,000,000 | $19.36 | $38,720,000 | 1,285,713 | −60.9% | plan? |
| Nov 14, 2016 SForm 4 → | Nov 16, 4:10 pm EST | Charles J HomcyDirector | — | — | — | 0 | — | plan? |
| Nov 3, 2016 JForm 5 → | Feb 14, 2017, 7:08 pm EST | Charles J HomcyDirector | 25,043 | — | — | 237,728 | — | plan? amended |
| Nov 3, 2016 JForm 4 → | Nov 7, 5:57 pm EST | Third Rock Ventures II, L.P. +510% Owner | 2,000,000 | — | — | 10,475,191 | — | plan? |
| Nov 3, 2016 JForm 4 → | Nov 7, 5:56 pm EST | Charles J HomcyDirector | — | — | — | 0 | — | plan? |
| Aug 1, 2016 MForm 4 → | Aug 3, 2:21 pm EDT | Hing ShamSenior VP, Research | 21,429 | $0.49 | $10,500 | 58,204 | — | plan? |
| Jul 31, 2016 AForm 5 → | Feb 14, 2017, 7:11 pm EST | Jung ChoiSee Remarks | 1,249 | $14.43 | $18,018 | 144,855 | — | plan? |
| Jul 31, 2016 AForm 5 → | Feb 14, 2017, 6:59 pm EST | Peter RadovichSee Remarks | 1,997 | $14.60 | $29,161 | 3,222 | — | plan? |
| Jul 31, 2016 AForm 5 → | Feb 14, 2017, 6:55 pm EST | Ted W LoveCEO and President, Director | 1,791 | $14.04 | $25,146 | 1,144,427 | — | plan? |
| Jul 1, 2016 DForm 4 → | Dec 16, 6:04 pm EST | Ted W LoveCEO and President, Director | 24,821 | $3.40 | $84,391 | 1,139,815 | — | plan? late |
| Feb 1, 2016 AForm 4/A → | Mar 14, 6:22 pm EDT | Jung ChoiSee Remarks | 749 | $16.09 | $12,051 | 143,606 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 9:49 pm EST | Jung ChoiSee Remarks | 749 | $16.09 | $12,051 | 168,606 | — | plan? amended |
| Feb 1, 2016 AForm 4 → | Feb 3, 9:48 pm EST | Eleanor RamosChief Medical Officer | 1,470 | $16.09 | $23,652 | 12,470 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 9:46 pm EST | Peter RadovichSee Remarks | 1,225 | $16.09 | $19,710 | 13,725 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 9:46 pm EST | Ted W LoveCEO and President, Director | 1,925 | $16.09 | $30,973 | 1,142,636 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 9:46 pm EST | John SchembriSee Remarks | 1,094 | $16.09 | $17,602 | 2,594 | — | plan? |
| Aug 17, 2015 PForm 4/A → | Mar 14, 2016, 6:20 pm EDT | Jung ChoiSee Remarks | 25,000 | $20.00 | $500,000 | 25,000 | — | plan? |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:55 pm EST | John SchembriSee Remarks | 1,500 | $21.57 | $32,360 | 1,500 | — | plan? late |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:43 pm EST | Mark L PerryDirector | 5,000 | $20.00 | $100,000 | 26,428 | +23.3% | plan? late |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:41 pm EST | Deval L PatrickDirector | 2,500 | $20.00 | $50,000 | 2,500 | — | plan? late amended |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:39 pm EST | Jung ChoiSee Remarks | 25,000 | $20.00 | $500,000 | 167,857 | +17.5% | plan? late amended |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:39 pm EST | Ted W LoveSee Remarks, Director | 10,000 | $20.00 | $200,000 | 2,500 | — | plan? late |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:34 pm EST | Hing ShamSVP of Chemistry | 2,000 | $20.00 | $40,000 | 36,775 | +5.75% | plan? late |
| Aug 17, 2015 PForm 4 → | Jan 7, 2016, 9:29 pm EST | Peter RadovichSee Remarks | 12,500 | $20.00 | $250,000 | 12,500 | — | plan? late |
| Aug 17, 2015 PForm 4/A → | Jan 7, 2016, 9:28 pm EST | Eleanor RamosChief Medical Officer | 12,000 | $20.86 | $250,280 | 1,000 | — | plan? |
| Aug 17, 2015 PForm 4 → | Dec 23, 8:39 pm EST | Eleanor RamosChief Medical Officer | 11,000 | $20.93 | $230,280 | 11,000 | — | plan? late amended |
| Aug 17, 2015 CForm 4 → | Aug 19, 4:34 pm EDT | Kevin P StarrDirector, 10% Owner | 14,189,476 | — | — | 2,285,713 | — | plan? |
| Aug 17, 2015 CForm 4 → | Aug 19, 4:33 pm EDT | Third Rock Ventures II, L.P. +410% Owner | 11,903,763 | — | — | 12,475,191 | — | plan? |
| Aug 17, 2015 CForm 4 → | Aug 19, 4:31 pm EDT | Third Rock Ventures III, L.P. +410% Owner | 2,285,713 | — | — | 2,285,713 | — | plan? |
| Aug 17, 2015 MForm 4 → | Aug 19, 4:05 pm EDT | Hing ShamSee Remarks | 25,490 | $0.9537 | $24,311 | 34,775 | — | plan? |